Page 27 - GTM-2-2
P. 27
Global Translational Medicine Use of cardio biomarker in diagnosis of AMI
Author contributions injury by assessment of the plasma ratio of myoglobin over
fatty acid-binding protein. Circulation, 92: 2848–2854.
Conceptualization: Vishal Modi
Writing – original draft: Rupali Shinde https://doi.org/10.1161/01.cir.92.10.2848
Writing – review & drafting: Isha Juwarwala, Vishal Modi, 9. Lewandrowski K, Chen A, Januzzi J, 2002, Cardiac markers
Chandni V. Chandarana for myocardial infarction. A brief review. Am J Clin Pathol,
118: S93–S99.
Ethics approval and consent to participate https://doi.org/10.1309/3ek7-yvv9-228c-e1xt
Not applicable. 10. Tilea I, Varga A, Serban RC, 2021, Past, present, and future
of blood biomarkers for the diagnosis of acute myocardial
Consent for publication infarction-promises and challenges. Diagnostics (Basel),
Not applicable. 11: 881.
https://doi.org/10.3390/diagnostics11050881
Availability of data
11. Reyes-Retana JA, Duque-Ossa LC, 2021, Acute myocardial
Not applicable. infarction biosensor: A review from bottom up. Curr Probl
Cardiol, 46: 100739.
References
https://doi.org/10.1016/j.cpcardiol.2020.100739
1. Ojha N, Dhamoon AS, 2022, Myocardial infarction. In: 12. High-sensitivity Troponin Test: Normal and High Levels.
StatPearls. Treasure Island, FL: StatPearls Publishing. Available from: https://www.medicinenet.com/high_
Available from: https://www.ncbi.nlm.nih.gov/books/ sensitivity_troponin_test_ranges_and_values/article.htm
nbk537076 [Last accessed on 2023 Jun 06].
[Last accessed on 2023 Jun 06].
2. Savonnet M, Rolland T, Cubizolles M, et al., 2021, Recent 13. Vasile VC, Jaffe AS, 2017, High-sensitivity cardiac troponin
advances in cardiac biomarkers detection: From commercial
devices to emerging technologies. J Pharm Biomed Anal, for the diagnosis of patients with acute coronary syndromes.
194: 113777. Curr Cardiol Rep, 19: 92.
https://doi.org/1010.1007/s11886-017-0904-4
https://doi.org/10.1016/j.jpba.2020.113777
14. Collinson PO, Boa FG, Gaze DC, 2001, Measurement of
3. Ahammad AJS, Choi YH, Koh K, et al., 2011,
Electrochemical detection of cardiac biomarker troponin I cardiac troponins. Ann Clin Biochem, 38: 423–449.
at gold nanoparticle-modified ITO electrode by using open https://doi.org/10.1177/000456320103800501
circuit potential. Int J Electrochem Sci, 6: 1906–1916. 15. Shave R, Dawson E, Whyte G, et al., 2002, The
4. Mahajan VS, Jarolim P, 2011, How to interpret elevated cardiospecificity of the third-generation cTnT assay after
cardiac troponin levels. Circulation, 124: 2350–2354. exercise-induced muscle damage. Med Sci Sports Exerc,
34: 651–654.
https://doi.org/10.1161/circulationaha.111.023697
https://doi.org/10.1097/00005768-200204000-00014
5. Rashid S, Malik A, Khurshid R, et al., 2019, The diagnostic
value of biochemical cardiac markers in acute myocardial 16. Chan D, Ng LL, 2010, Biomarkers in acute myocardial
infarction. In: Myocardial Infarction. London, UK: infarction. BMC Med, 8: 34.
IntechOpen.
https://doi.org/10.1186/1741-7015-8-34
https://doi.org/10.5772/intechopen.76150
17. Hazen SL, Heinecke JW, 1997, 3-chlorotyrosine, a specific
6. Falahati A, Sharkey SW, Christensen D, et al., 1999, marker of myeloperoxidase-catalyzed oxidation, is markedly
Implementation of serum cardiac troponin I as marker elevated in low density lipoprotein isolated from human
for detection of acute myocardial infarction. Am Heart J, atherosclerotic intima. J Clin Invest, 99: 2075–2081.
137: 332–337.
https://doi.org/10.1172/JCI119379
https://doi.org/10.1053/hj.1999.v137.92412
18. Thukkani AK, McHowat J, Hsu FF, et al., 2003, Identification
7. Garg P, Morris P, Fazlanie AL, et al., 2017, Cardiac of alpha-chloro fatty aldehydes and unsaturated
biomarkers of acute coronary syndrome: From history lysophosphatidylcholine molecular species in human
to high-sensitivity cardiac troponin. Intern Emerg Med, atherosclerotic lesions. Circulation, 108: 3128–3133.
12: 147–155.
https://doi.org/10.1161/01.cir.0000104564.01539.6a
https://doi.org/10.1007/s11739-017-1612-1
19. Beckmann JS, Ye YZ, Anderson PG, et al., 1994, Extensive
8. Van Nieuwenhoven FA, Kleine AH, Wodzig KH, et al., 1995, nitration of protein tyrosines in human atherosclerosis
Discrimination between myocardial and skeletal muscle detected by immunohistochemistry. Biol Chem Hoppe
Volume 2 Issue 2 (2023) 9 https://doi.org/10.36922/gtm.0403

